201. アンジェルマン症候群 Angelman syndrome Clinical trials / Disease details

臨床試験数 : 25 / 薬物数 : 40 - (DrugBank : 11) / 標的遺伝子数 : 22 - 標的パスウェイ数 : 20

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03235037 (ClinicalTrials.gov)	November 26, 2013	28/7/2017	Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome	Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome	Angelman Syndrome	Drug: Levodopa	Bennett Lavenstein	NULL	Completed	18 Months	16 Years	All	10	N/A	NULL
2	NCT01281475 (ClinicalTrials.gov)	January 2011	20/1/2011	A Trial of Levodopa in Angelman Syndrome	A Phase 2 Randomized Placebo-Controlled Trial of Levodopa in Angelman Syndrome	Angelman Syndrome	Drug: Levodopa;Drug: Placebo Oral Capsule	Wen-Hann Tan	Rady Children's Hospital, San Diego;University of California, San Francisco;Baylor College of Medici ...	Completed	4 Years	12 Years	All	67	Phase 2/Phase 3	United States
3	NCT00829439 (ClinicalTrials.gov)	January 2009	26/1/2009	Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome	A Dose-escalation Tolerability Study of Levodopa/Carbidopa in Angelman Syndrome	Angelman Syndrome	Drug: Levodopa /Carbidopa (4:1)	Boston Children’s Hospital	NULL	Completed	4 Years	12 Years	All	16	Phase 1	United States

First Previous1Next Last